{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:48:18Z","timestamp":1770479298841,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[1998,6]]},"DOI":"10.1053\/hj.1998.v135.90302","type":"journal-article","created":{"date-parts":[[2004,12,22]],"date-time":"2004-12-22T14:55:56Z","timestamp":1103727356000},"page":"S343-S352","source":"Crossref","is-referenced-by-count":9,"special_numbering":"S2","title":["New therapies for unstable angina and non\u2013Q-wave myocardial infarction: Recent clinical trials"],"prefix":"10.1053","volume":"135","author":[{"given":"Marc","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/hj.1998.v135.90302_BIB1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0002-9149(88)90924-1","article-title":"Angiographic demonstration of a common link between unstable angina pectoris and non-Q wave acute myocardial infarction","volume":"61","author":"Ambrose","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1053\/hj.1998.v135.90302_BIB2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/01.CIR.74.1.6","article-title":"Anatomic-physiologic links between acute coronary syndromes","volume":"74","author":"Gorlin","year":"1986","journal-title":"Circulation"},{"key":"10.1053\/hj.1998.v135.90302_BIB3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM199201233260406","article-title":"The pathogenesis of coronary artery disease and the acute coronary syndromes","volume":"326","author":"Fuster","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/hj.1998.v135.90302_BIB4","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199105303242206","article-title":"Heparin","volume":"324","author":"Hirsh","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1053\/hj.1998.v135.90302_BIB5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V79.1.1.1","article-title":"Low molecular weight heparin","volume":"79","author":"Hirsh","year":"1992","journal-title":"Blood"},{"key":"10.1053\/hj.1998.v135.90302_BIB6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/hrt.74.4.337","article-title":"New directions in anticoagulant and antiplatelet treatment","volume":"74","author":"Simoons","year":"1995","journal-title":"Br Heart J"},{"issue":"suppl L","key":"10.1053\/hj.1998.v135.90302_BIB7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/eurheartj\/16.suppl_L.68","article-title":"Clinical management of unstable angina: the place of antithrombins and platelet GP IIb\/IIIa receptor blockers","volume":"16","author":"Knudtson","year":"1995","journal-title":"Eur Heart J"},{"issue":"suppl","key":"10.1053\/hj.1998.v135.90302_BIB8","doi-asserted-by":"crossref","first-page":"471S","DOI":"10.1378\/chest.108.4_Supplement.471S","article-title":"New antithrombotics","volume":"108","author":"Weitz","year":"1995","journal-title":"Chest"},{"key":"10.1053\/hj.1998.v135.90302_BIB9","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/0735-1097(93)90540-H","article-title":"Prospective comparison of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy","volume":"22","author":"Cohen","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/hj.1998.v135.90302_BIB10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM198308183090703","article-title":"Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration Cooperative Study","volume":"309","author":"Lewis","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1053\/hj.1998.v135.90302_BIB11","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJM198511283132201","article-title":"Aspirin, sulfinpyrazone or both in unstable angina: results of a Canadian multicenter trial","volume":"313","author":"Cairns","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1053\/hj.1998.v135.90302_BIB12","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198810273191701","article-title":"Aspirin, heparin, or both to treat acute unstable angina","volume":"319","author":"Theroux","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1053\/hj.1998.v135.90302_BIB13","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)92336-G","article-title":"Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease","volume":"336","year":"1990","journal-title":"Lancet"},{"key":"10.1053\/hj.1998.v135.90302_BIB14","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/01.CIR.88.5.2045","article-title":"Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina","volume":"88","author":"Theroux","year":"1993","journal-title":"Circulation"},{"key":"10.1053\/hj.1998.v135.90302_BIB15","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1161\/01.CIR.91.7.1929","article-title":"Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes","volume":"91","author":"Granger","year":"1995","journal-title":"Circulation"},{"key":"10.1053\/hj.1998.v135.90302_BIB16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199207163270301","article-title":"Reactivation of unstable angina after the discontinuation of heparin","volume":"327","author":"Theroux","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/hj.1998.v135.90302_BIB17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.CIR.89.1.81","article-title":"Combination antithrombotic therapy in unstable rest angina and non\u2013Q-wave infarction in nonprior aspirin users: primary end points from the ATACS trial","volume":"89","author":"Cohen","year":"1994","journal-title":"Circulation"},{"key":"10.1053\/hj.1998.v135.90302_BIB18","series-title":"Unstable angina: diagnosis and management","author":"Braunwald","year":"1994"},{"key":"10.1053\/hj.1998.v135.90302_BIB19","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1161\/01.CIR.90.4.1631","article-title":"randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes","volume":"90","year":"1994","journal-title":"Circulation"},{"key":"10.1053\/hj.1998.v135.90302_BIB20","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/01.CIR.90.4.1624","article-title":"Hirudin in acute myocardial infarction: safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A trial","volume":"90","year":"1994","journal-title":"Circulation"},{"key":"10.1053\/hj.1998.v135.90302_BIB21","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJM199609123351103","article-title":"A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes","volume":"335","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/hj.1998.v135.90302_BIB22","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/01.CIR.94.5.911","article-title":"Hirudin in acute myocardial infarction: thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9B trial","volume":"94","author":"Antman","year":"1996","journal-title":"Circulation"},{"key":"10.1053\/hj.1998.v135.90302_BIB23","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199509213331204","article-title":"Treatment with bivalirudin (hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina","volume":"333","author":"Bittl","year":"1995","journal-title":"N Engl J Med"},{"issue":"suppl L","key":"10.1053\/hj.1998.v135.90302_NEWBIB24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/eurheartj\/16.suppl_L.11","article-title":"The role of platelets in arterial thrombosis and the rationale for blockade of platelet GPIIb\/IIIa receptors as antithrombotic therapy","volume":"16","author":"Coller","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1053\/hj.1998.v135.90302_NEWBIB25","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJM199506083322306","article-title":"Platelet glycoprotein IIb\/IIIa receptors in cardiovascular medicine","volume":"332","author":"Lefkovits","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1053\/hj.1998.v135.90302_NEWBIB26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/oxfordjournals.eurheartj.a014698","article-title":"Platelet glycoprotein IIb\/IIIa receptor antagonists in coronary artery disease","volume":"17","author":"Lefkovits","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1053\/hj.1998.v135.90302_BIB27","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","article-title":"Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty","volume":"330","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/hj.1998.v135.90302_BIB28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jama.1997.03550060055036","article-title":"Long-term protection from myocardial ischemic events in a randomized trial of brief integrin B3 blockade with percutaneous coronary intervention","volume":"278","author":"Topol","year":"1997","journal-title":"JAMA"},{"key":"10.1053\/hj.1998.v135.90302_BIB29","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199706123362401","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/hj.1998.v135.90302_BIB30","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(96)10452-9","article-title":"Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/hj.1998.v135.90302_BIB31","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(96)10172-0","article-title":"Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/hj.1998.v135.90302_BIB32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.CIR.94.1.1","article-title":"Meeting highlights: American College of Cardiology 45th Annual Scientific Session, Orlando, Fla., March 24-27, 1996","volume":"94","author":"Ferguson","year":"1996","journal-title":"Circulation"},{"key":"10.1053\/hj.1998.v135.90302_BIB33","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1161\/01.CIR.94.5.899","article-title":"Platelet membrane receptor glycoprotein IIb\/IIIa antagonism in unstable angina: the Canadian Lamifiban Study","volume":"94","author":"Theroux","year":"1996","journal-title":"Circulation"},{"key":"10.1053\/hj.1998.v135.90302_BIB34","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/hj.1998.v135.90302_BIB35","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2141.1992.tb06437.x","article-title":"Inhibition of thrombin generation by heparin and low molecular weight (LMW) heparins in the absence and presence of platelet factor 4 (PF4)","volume":"82","author":"Padilla","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1053\/hj.1998.v135.90302_BIB36","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1172\/JCI110891","article-title":"Protection of factor Xa from neutralization by the heparin-antithrombin complex","volume":"71","author":"Teitel","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1053\/hj.1998.v135.90302_BIB37","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJM198610303151801","article-title":"Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis","volume":"315","author":"Hull","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1053\/hj.1998.v135.90302_BIB38","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJM198902093200604","article-title":"Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction","volume":"320","author":"Turpie","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1053\/hj.1998.v135.90302_BIB39","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1056\/NEJM197910183011602","article-title":"Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis","volume":"301","author":"Hull","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1053\/hj.1998.v135.90302_BIB40","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0140-6736(85)90459-3","article-title":"Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis","volume":"2","author":"Lagerstedt","year":"1985","journal-title":"Lancet"},{"key":"10.1053\/hj.1998.v135.90302_BIB41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.90.1.61","article-title":"Persistent activation of coagulation mechanism in unstable angina and myocardial infarction","volume":"90","author":"Merlini","year":"1994","journal-title":"Circulation"},{"key":"10.1053\/hj.1998.v135.90302_BIB42","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1161\/01.CIR.91.10.2520","article-title":"Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina","volume":"91","author":"Hoffmeister","year":"1995","journal-title":"Circulation"},{"key":"10.1053\/hj.1998.v135.90302_BIB43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.me.40.020189.000335","article-title":"Heparin-induced thrombocytopenia","volume":"40","author":"Warkentin","year":"1989","journal-title":"Annu Rev Med"},{"key":"10.1053\/hj.1998.v135.90302_BIB44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0038-1642376","article-title":"Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (fragmin) in patients with venous thromboembolism and contraindications to coumarin","volume":"71","author":"Monreal","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1053\/hj.1998.v135.90302_BIB45","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/106002809603000508","article-title":"Enoxaparin for unstable angina and ancrod for cardiac surgery following heparin allergy (case report)","volume":"30","author":"Smith","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1053\/hj.1998.v135.90302_BIB46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0735-1097(95)80001-W","article-title":"Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia","volume":"26","author":"Gurfinkel","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/hj.1998.v135.90302_BIB47","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(96)91270-2","article-title":"Low-molecular-weight heparin during instability in coronary artery disease","volume":"347","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/hj.1998.v135.90302_BIB48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.96.1.61","article-title":"Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease","volume":"96","author":"Klein","year":"1997","journal-title":"Circulation"},{"key":"10.1053\/hj.1998.v135.90302_BIB49","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2141.1995.tb08346.x","article-title":"Heparin-induced thrombocytopenia","volume":"89","author":"Chong","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1053\/hj.1998.v135.90302_BIB50","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease","volume":"337","author":"Cohen","year":"1997","journal-title":"N Engl J Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870398000982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870398000982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T22:00:14Z","timestamp":1586037614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870398000982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["S0002870398000982"],"URL":"https:\/\/doi.org\/10.1053\/hj.1998.v135.90302","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}